2022
DOI: 10.1111/all.15320
|View full text |Cite
|
Sign up to set email alerts
|

Selenomethionine attenuates allergic effector responses in human primary mast cells

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
0
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(2 citation statements)
references
References 5 publications
0
0
0
Order By: Relevance
“…According to Zhao et al. (2022), selenomethionine‐induced reduction of FcεRI expression and IgE binding could potentially serve as an interesting mechanism to prevent mast cell activation and degranulation. Taken together, our results suggested that Se‐TPS has effects of suppressing FA.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…According to Zhao et al. (2022), selenomethionine‐induced reduction of FcεRI expression and IgE binding could potentially serve as an interesting mechanism to prevent mast cell activation and degranulation. Taken together, our results suggested that Se‐TPS has effects of suppressing FA.…”
Section: Discussionmentioning
confidence: 99%
“…ated the clinical symptoms of OVA-allergic mice by regulating intestinal flora and immune cell differentiation. According toZhao et al (2022), selenomethionine-induced reduction of FcεRI expression and IgE binding could potentially serve as an interesting mechanism to prevent mast cell activation and degranulation. Taken together, our results suggested that Se-TPS has effects of suppressing FA.Intestinal epithelial dysfunction is one of the main symptoms associated with FA.…”
mentioning
confidence: 99%